U.S. Pharmacist eNewsletter
June 2023

Impact of Elevated BMI on MDD Clinical Outcomes
Previous research has established that individuals with major depressive disorder (MDD) are at increased risk of obesity. In a recent publication in the Journal of Affective Disorders, researchers employed data from the European Group for the Study of Resistant Depression to examine clinical outcomes associated with BMI in MDD. Learn more about the results of this study.

Advertisement

Incidence of Hyperlipidemia, Associated Risk Factors Among MDD Patients
Previous research has established that among patients with major depressive disorder (MDD), the incidences of glucose and lipid abnormalities are common. In a recent publication, researchers conducted a cross-sectional study to examine the prevalence and associated factors contributing to abnormal lipid metabolism in MDD patients with abnormal glucose metabolism. Learn more about the results of this study.

Online Cognitive Behavioral Therapy Efficacious
In a recent publication in Frontiers Psychiatry, researchers conducted a nonrandomized, controlled study to compare the efficacy of a therapist-supported, online/electronically cognitive behavioral therapy program to in-person therapy in individuals diagnosed with major depressive disorder. This study revealed both in-person and online/electronically cognitive behavioral therapy produced meaningful improvements in depressive symptoms and quality of life. Read more.


Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement